# Sun Pharmaceutical Industries, Inc.: Methylphenidate Hydrochloride Tablet, Extended Release shortage update (unavailable from this maker)

**Score:** 60/100

| Field | Value |
|---|---|
| Manufacturer | Sun Pharmaceutical Industries, Inc. |
| Drug | Methylphenidate Hydrochloride Tablet, Extended Release |
| Dosage form | Tablet |
| Therapeutic category | Psychiatry |
| Status | Current |
| Stage | Shortage revised (availability or dates changed) |
| Availability | Unavailable |
| Reason | Discontinuation of the manufacture of the drug |
| Presentations affected | 4 |
| Package NDCs | 57664-606-88, 57664-609-88, 57664-607-88, 57664-608-88 |
| Manufacturer supply note | Currently not marketed |
| First posted | 2023-07-26 |
| Updated | 2026-10-30 |

## Why this score
- Shortage details just changed.
- Unavailable from this manufacturer.

Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list) (https://dps.fda.gov/drugshortages). Last refreshed: 2026-11-04T06:10:12.565Z.
From the openFDA drug shortages endpoint, which mirrors the FDA drug shortage list and can lag it by days. Availability and recovery notes are the manufacturer's own statements to FDA. Company and product level only. Verify with FDA and the manufacturer before acting.